The Impact of Coronavirus Disease 2019 on Pediatric Asthma in the United States

Pediatr Clin North Am. 2021 Oct;68(5):1119-1131. doi: 10.1016/j.pcl.2021.05.012. Epub 2021 May 21.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has caused severe economic and health impacts in the United States, and the impact is disproportionately more in socially disadvantages areas. The available data, albeit limited in children, suggest that the initial concerns of the potential of serious impact of COVID-19 illness in children with asthma are unproven so far. The reduction in asthma morbidities is due to improved adherence, COVID-19 control measures, school closures, and decreased exposure to allergens and viral infections in children. During the pandemic, asthma guidelines were updated to guide physicians in asthma care. In the face of unprecedented time, it is important to be vigilant, adhere to treatment guidelines, and implement preventive measures to eradicate the virus and improve outcomes in children with asthma.

Keywords: COVID-19; Pediatric asthma; United States.

Publication types

  • Review

MeSH terms

  • Asthma / enzymology*
  • Asthma / therapy*
  • COVID-19 / epidemiology*
  • COVID-19 / therapy
  • Child
  • Humans
  • Medication Adherence
  • Patient Education as Topic / methods*
  • School Health Services / organization & administration*
  • Schools / organization & administration
  • Telemedicine / statistics & numerical data
  • United States